【正文】 anuscript、response to thereviewers、cover letter等），最后下載 pdf，查看無誤后，即可到投稿主頁approve submission 或直接 submit it。（二）投稿經(jīng)驗總結(jié)正確選擇對口的SCI期刊。這種投機取巧之事最好不要做，因為許多雜志之間的編委是相同的，一旦同一篇文章兩次發(fā)到同一個編委或?qū)徃迦耸种?，那后果就不堪設(shè)想，尤其那些投遞手稿 時就需要轉(zhuǎn)移協(xié)議的，切記主要版權(quán)問題。后來次日編輯就回信說reject the paper，不知道這是巧合還是帶著性格。簽名時盡量不要代簽，以免被編輯發(fā)現(xiàn)時的尷尬。要了解此刊是否需要審稿費和版面費？大家都知道版面費一般都是用美元衡量的，建議 最好選擇不需要版面費的（不用彩圖也收版面費的）。我的感覺是好一點雜志審稿周期短一點，而往往是差 一點的雜志卻老是拖，曾經(jīng)遇到一個 ：原因是找不到審稿人，多少審稿人推脫最近很忙第四篇：Elsevier期刊投稿狀態(tài)以及回復(fù)信件 letter：主要任務(wù)是介紹文章主要創(chuàng)新以及聲明沒有一稿多投 Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”.No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for would like to declare on behalf of my coauthors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in the authors listed have approved the manuscript that is this work, we evaluated ??(簡要介紹一下論文的創(chuàng)新性).I hope this paper is suitable for “Journal Name”.The following is a list of possible reviewers for your consideration: 1)Name AEmail: 2)Name BEmail: We deeply appreciate your consideration of our manuscript, and we look forward to receiving ments from the you have any queries, please don’t hesitate to contact me at the address you and best sincerely, Corresponding author: Name: Email: 二、催稿信：詢問稿件處理到聲明步驟 Dear Prof.: Sorry for disturbing am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”.(ID: 文章稿號), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months am just wondering that my manuscript has been sent to reviewers or not? I would be greatly appreciated if you could spend some of your time check the status for am very pleased to hear from you on the reviewer’s you very much for your regards!Yours sincerely, Corresponding author: Name: Email: 三、修改稿Cover letter Dear Dr/ Prof..（寫上負(fù)責(zé)你文章編輯的姓名，顯得尊重，因為第一次的投稿不知道具體負(fù)責(zé)的編輯，只能用通用的Editors）: On behalf of my coauthors, we thank you very much for giving us an opportunity to revise our manuscript, we appreciate editor and reviewers very much for their positive and constructive ments and suggestions on our manuscript entitled “Paper Title”.(ID: 文章稿號).We have studied reviewer’s ments carefully and have made revision which marked in red inthe have tried our best to revise our manuscript according to the please find the revised version, which we would like to submit for your kind would like to express our great appreciation to you and reviewers for ments on our forward to hearing from you and best sincerely, Corresponding author: Name: Email: 四、修改稿回答審稿人的意見（最重要的部分）List of Responses Dear Editors and Reviewers: Thank you for your letter and for the reviewers’ ments concerning our manuscript entitled “Paper Title”(ID: 文章稿號).Those ments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our have studied ments carefully and have made correction which we hope meet with portion are marked in red in the main corrections in the paper and the responds to the reviewer’s ments are as flowing: Responds to the reviewer’s ments: Reviewer 1: to ment:(??簡要列出意見??)Response: to ment:(??簡要列出意見??)Response: 。(3)版權(quán)問題。但是Elsevier旗下期刊對投稿的模板沒什么要求，只要你比較注意排版，看著舒服就好。不過要在Letter to Editor中要說明這是同一個論文。2 Elsevier投稿狀態(tài)總結(jié)(1)Submitted to Journal 剛提交的狀態(tài)(2)Manuscript received by Editorial Office 就是你的文章到了編輯手里了，證明投稿成功(3)With editor 如果在投稿的時候沒有要求選擇編輯，就先到主編那，主編會分派給別的編輯。如果被邀請審稿人不想審，就會decline，編輯會重新邀請別的審稿人。一步會比較快，但也有慢的。(11)Transfer copyright form 簽版權(quán)協(xié)議(12)uncorrected proof 等待你校對樣稿(13)In Press, Corrected Proof 文章在印刷中，且該清樣已經(jīng)過作者校對(14)Manuscript Sent to Production 排版(15)in production 出版中 備注：現(xiàn)在Elsevier的絕大多數(shù)期刊，增加了Technical Checking這一關(guān)，由專門的Editorial office來審查論文的語言、格式、排版、圖片等等，也就是說，審查你的投稿是否符合Guide for Authors中的各項要求。之后，如果不出意外，論文狀態(tài)將會再次變成With Editor，這里的Editor才是真正的期刊主編。那么一篇文章能不能發(fā)表SCI雜志，有哪些關(guān)鍵點？MedSci總結(jié)有幾個關(guān)鍵性環(huán)節(jié)：首先當(dāng)然是文章的設(shè)計，MedSci編輯經(jīng)常發(fā)現(xiàn)作者遞送過來的文章一個重要的問題就是設(shè)計存在缺陷，不是分組缺少，就是樣本量過低，或缺少對照，或各部分實驗邏輯性不強，這些致命性缺陷是困擾許多作者的關(guān)鍵問題。因此，許多作者寫習(xí)慣了中文文章，這些寫作方式來寫作英文文章，實在差強人意。英文語言。這里面又分為選擇雜志，投遞，與編輯交流等多個環(huán)節(jié)。而相對幾千種SCI期刊來說，確實不夠。只要到每個雜志的首頁，打開submit paper一欄，點擊Introduction查看或下載即可。一般不建議用國內(nèi)的信箱，因為不少國外的雜志對國內(nèi)的信箱是屏蔽的。一般來說，投稿后，一周以內(nèi)便可以進(jìn)入審稿狀態(tài)，13個月會有初審結(jié)果。程序是進(jìn)入投稿主頁main menu，點擊revise，仍然按照原先程序投遞（近似于4），切記把修改的標(biāo)題、摘要和回復(fù)信等內(nèi)容要修改。一般校樣作者自行核對，我們MedSci有專門的校樣工作人員，可以檢查出在校樣過程中，發(fā)現(xiàn)的一些細(xì)微錯誤。一般文章確認(rèn)接收后，有付款的過程。建議選擇我們的“發(fā)表支持（publication support)服務(wù)”，我們會全程為大家提供專業(yè)的服務(wù)。當(dāng)然，少數(shù)情況，低分雜志投不中，有可能是雜志選擇不合適，有時甚至可以向略高一些分?jǐn)?shù)的雜志進(jìn)行投稿，也有投中的。但這也與你的投稿目的有關(guān)，若十分自信文章的創(chuàng)新性和中肯意見，你可以從參考文獻(xiàn)中挑選大專家。如何提高一次投稿的成功率？文章本身的創(chuàng)新性是第一位因素，對口期刊選擇、文章格式完美、語句通順（尤其符合英文習(xí)慣）等也很重要。這一點是衡量一位科研工作者的嚴(yán)謹(jǐn)程度，建議大家認(rèn)真閱讀Introduction for submission，逐條地改正，以防延誤同行評審時間